It’s shaping up to be quite the week for Amazon. Monday and Tuesday mark Amazon’s “Prime Day,” its largest annual sales event. On Wednesday, the House Judiciary Committee is scheduled to begin marking-up a package of five antitrust bills designed to target the online retail giant, along with other major tech companies.
The Taxpayers Protection Alliance (TPA) sent a letter to U.S. Senators urging them to oppose S.1
or centuries man has attempted harm reduction by lowering the risk of sexual relations with condoms. And, from oven mitts to helmets, many more innovations have come about in light of risky behaviors. Interestingly, some harm reduction efforts have come with plenty of naysayers. Some innovations have found friends and foes in taxpayer-funded federal agencies meant to protect Americans.
As the economy slowly but surely recovers from the coronavirus pandemic, businesses are desperate to hire back workers who were told to go home during the height of lockdown restrictions. In a remarkable turnaround, there has already been a flurry of wage hikes, increases in signing bonuses, and contract renewals offered by companies reopening their doors. But all of this may change if the Biden administration picks the wrong personnel to staff operations at federal agencies such as the Department of Labor (DOL).
The leading Republican on these bills Rep. Ken Buck (R-Co.), along with some of his allies, accused folks like me of “lying” about the actual impact these bills would have in ways that are tangible to the average consumer. Well, turns out we critics were right because the leading Democrat in the effort, Antitrust Subcommittee Chairman David Cicilline (D-R.I.) just confirmed that one reform in the broader package would indeed prevent companies like Apple from preloading applications onto devices they sell like smartphones.
Earlier Today, TPA led a coalition of 8 groups to call for an investigation of the IRS after the ProPublica Leak.
There is a tempest brewing at the Food and Drug Administration (FDA). Recently, the agency opted to approve aducanumab, which is the first drug on the market potentially capable of slowing down Alzheimer’s disease. The medication was approved amid considerable controversy with many detractors of the purported wonder drug. And now, three medical experts on the FDA’s advisory committee have resigned in protest.
The Taxpayers Protection Alliance (TPA) is encouraged by Leader Kevin McCarthy, Representative Jim Jordan, and Representative Darrell Issa’s principled stances against big government solutions in the tech sector.
The Taxpayers Protection Alliance (TPA) is greatly concerned about the direction of the Federal Trade Commission (FTC) after the confirmation of Lina Khan as head of the commission. Khan has expressed public contempt for many of the companies whose dealings she will oversee.
The desire to weaponize antitrust against big tech companies these politicians see as biased against conservatives has opened the floodgates for Democrats to use it in all sorts of ways.
